Both prospective and retrospective studies and also meta-analyses have described the poor prognostic role of elevated baseline C-reactive protein (CRP) (1–4), cross-linked fibrin degradation products (D-dimer) (5–8), lactate dehydrogenase (LDH) (9–12), and decreased albumin (13–15) in cancer. Here, CRP is linked to cancer.